Načítá se...
Capitalizing on Tumor genotyping: Towards the design of mutation specific inhibitors of Phosphoinsitide-3-Kinase
Phosphatidylinositide-3-kinases (PI3K) PI3Kα, is a lipid kinase frequently mutated in several cancer types. Under normal physiological conditions it initiates a number of signaling pathways by recruiting other kinases, such as Akt, to the plasma membrane. The mutations observed in tumors increase PI...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3079044/ https://ncbi.nlm.nih.gov/pubmed/21035489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.advenzreg.2010.09.013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|